Rahul Sarugaser Archives - Page 3 of 3

Markets

Raymond James ups Protech Home Medical PT to $3 (Canadian) from $2.00

Raymond James raised its price target for Protech Home Medical (TSXV:PTQ) to $3 (Canadian) from $2.00, citing an update to its valuation methodology. The stock closed at $2.05 on Jan. 21. Protech is a provider of...

January 22, 2021

Markets

Raymond James starts Protech Home Medical at OP; PT $2 (Canadian)

Raymond James initiated coverage of Protech Home Medical (PTQ-TSXV) with an “outperform” rating and price target of $2 (Canadian). The stock closed at $1.44 on Dec. 14. Protech provides clinical respiratory equipment...

December 15, 2020

Markets

Raymond James starts Perimeter Medical Imaging at OP; PT $3 (Canadian)

Raymond James initiated coverage of Perimeter Medical Imaging AI (TSXV:PINK) with an “outperform” rating and price target of $3 (Canadian). The stock closed at $2.19 on Nov. 6. Perimeter is commercializing its Optical...

November 9, 2020

Markets

Raymond James sees Profound Medical insulated from COVID-19 fallout

Raymond James reiterated that Profound Medical (TSX:PRN; NASDAQ:PROF) remains its “analyst current favorite” and “2020 Best Pick,” saying Profound is “particularly insulated from the current economic fallout of COVID-19...

March 12, 2020

Markets

Raymond James starts Cardiol Therapeutics at OP 2; PT $5

Raymond James launched coverage of Cardiol Therapeutics (TSX:CRDL) with an “outperform 2” rating and price target of $5 (Canadian). The stock closed $4 on Jan.23. Cardiol’s therapeutic strategy is focused around the...

January 24, 2020

Markets

Raymond James starts Profound Medical at OP; PT $4

Raymond James initiated coverage of Profound Medical (TSX:PRN; OTCQX:PRFMF) with an “outperform” rating and price target of $4. The stock closed at 92 cents on Aug. 23. “With its highly experienced management team...

August 26, 2019

Markets

Paradigm ups Profound Medical PT to $3

Paradigm Capital raised its price target for Profound Medical (TSXV:PRN) to $3 from $2.25 after the company completed an upsized equity financing of $34.5-million. The stock closed at $1.05 on March 20. “We see this...

March 21, 2018

Tag - Rahul Sarugaser

Raymond James ups Protech Home Medical PT to $3 (Canadian) from $2.00

Raymond James starts Protech Home Medical at OP; PT $2 (Canadian)

Raymond James starts Perimeter Medical Imaging at OP; PT $3 (Canadian)

Raymond James sees Profound Medical insulated from COVID-19 fallout

Raymond James starts Cardiol Therapeutics at OP 2; PT $5

Raymond James starts Profound Medical at OP; PT $4

Paradigm ups Profound Medical PT to $3

General

More